These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Magnetic resonance imaging of the effects of infliximab on perianal fistulizing Crohn's disease. Van Assche G; Vanbeckevoort D; Bielen D; Coremans G; Aerden I; Noman M; D'Hoore A; Penninckx F; Marchal G; Cornillie F; Rutgeerts P Am J Gastroenterol; 2003 Feb; 98(2):332-9. PubMed ID: 12591051 [TBL] [Abstract][Full Text] [Related]
4. Treatment of perianal fistulas in Crohn's disease by local injection of antibody to TNF-alpha accounts for a favourable clinical response in selected cases: a pilot study. Asteria CR; Ficari F; Bagnoli S; Milla M; Tonelli F Scand J Gastroenterol; 2006 Sep; 41(9):1064-72. PubMed ID: 16938720 [TBL] [Abstract][Full Text] [Related]
5. Combining infliximab with 6-mercaptopurine/azathioprine for fistula therapy in Crohn's disease. Ochsenkühn T; Göke B; Sackmann M Am J Gastroenterol; 2002 Aug; 97(8):2022-5. PubMed ID: 12190171 [TBL] [Abstract][Full Text] [Related]
12. Clinical advantages of combined seton placement and infliximab maintenance therapy for perianal fistulizing Crohn's disease: when and how were the seton drains removed? Tanaka S; Matsuo K; Sasaki T; Nakano M; Sakai K; Beppu R; Yamashita Y; Maeda K; Aoyagi K Hepatogastroenterology; 2010; 57(97):3-7. PubMed ID: 20422862 [TBL] [Abstract][Full Text] [Related]
13. Review article: Medical therapy for fistulizing Crohn's disease. Bressler B; Sands BE Aliment Pharmacol Ther; 2006 Nov; 24(9):1283-93. PubMed ID: 17059510 [TBL] [Abstract][Full Text] [Related]
14. Perianal fistulizing Crohn's disease: a call to action. Kamm MA; Ng SC Clin Gastroenterol Hepatol; 2008 Jan; 6(1):7-10. PubMed ID: 18063415 [TBL] [Abstract][Full Text] [Related]
15. [Management of perianal fistulizing Crohn's disease: a conservative approach]. Dignass AU Dtsch Med Wochenschr; 2005 Aug; 130(34-35):1968. PubMed ID: 16123902 [No Abstract] [Full Text] [Related]
16. Infliximab in fistulizing Crohn's disease. Osterman MT; Lichtenstein GR Gastroenterol Clin North Am; 2006 Dec; 35(4):795-820. PubMed ID: 17129814 [TBL] [Abstract][Full Text] [Related]
17. Combined seton placement, infliximab infusion, and maintenance immunosuppressives improve healing rate in fistulizing anorectal Crohn's disease: a single center experience. Topstad DR; Panaccione R; Heine JA; Johnson DR; MacLean AR; Buie WD Dis Colon Rectum; 2003 May; 46(5):577-83. PubMed ID: 12792431 [TBL] [Abstract][Full Text] [Related]
18. Anti-TNF-alpha (infliximab) used as induction treatment in case of active proctitis in a multistep strategy followed by definitive surgery of complex anal fistulas in Crohn's disease: a preliminary report. van der Hagen SJ; Baeten CG; Soeters PB; Russel MG; Beets-Tan RG; van Gemert WG Dis Colon Rectum; 2005 Apr; 48(4):758-67. PubMed ID: 15750797 [TBL] [Abstract][Full Text] [Related]
19. Treatment of fistulizing Crohn's disease. Judge TA; Lichtenstein GR Gastroenterol Clin North Am; 2004 Jun; 33(2):421-54, xi-xii. PubMed ID: 15177547 [TBL] [Abstract][Full Text] [Related]